Ramón García Sanz, MD, PhD
Hematologist at the University Hospital of Salamanca since 1994, head of the Molecular Laboratory Unit since April 2019. Researcher at the Cancer Research Center of Salamanca since 2001. Associate professor at the School of Medicine in the University of Salamanca since 2007.
He pursued medical studies in the University of Salamanca between 1982 and 1988, and he specialized in hematology between 1990 and 1994. His PhD work was about multiple myeloma biology, and he was awarded with the Special Mention 1993/94. He also did postdoctoral studies in the Immunology Department of the Erasmus University of Rotterdam, The Netherlands, and Anthony Nola Research Institute, London, UK.
Dr. García-Sanz is principal investigator and co-investigator in Multiple Myeloma, Hodgkin’s Lymphoma, and Waldenström’s macroglobulinemia. He also researches in blood biology and standardization in the hematology laboratory.
Ramón García-Sanz has authored or co-authored more than 380 original research articles indexed in PubMed, as well as publications in Spanish, with more than 30,000 citations and an H index of 86 in google.scholar (74 in WOS). He actively participates in the Spanish groups GEM/PETHEMA and GELTAMO focusing on myeloma biology, minimal residual disease detection, and global studies in Hodgkin’s lymphoma and Waldenström’s macroglobulinemia. He is the current coordinator of the hematological tumors program of the CIBERONC network and the coordinator of the Hodgkin’s Lymphoma subcommittee of the GELTAMO. He also participated in the board of Spanish Society of Hematology, where he was the president between 2019 and 2022.
